ASPEN AEROGELS INC (ASPN) Stock Fundamental Analysis
NYSE:ASPN • US04523Y1055
3.61 USD
-0.01 (-0.28%)
At close: Feb 20, 2026
3.61 USD
0 (0%)
After Hours: 2/20/2026, 8:17:33 PM
We assign a fundamental rating of 3 out of 10 to ASPN. ASPN was compared to 83 industry peers in the Chemicals industry. The financial health of ASPN is average, but there are quite some concerns on its profitability. ASPN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ASPN has reported negative net income.
- In the past year ASPN had a positive cash flow from operations.
- ASPN had negative earnings in 4 of the past 5 years.
- ASPN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- ASPN has a Return On Assets of -62.12%. This is amonst the worse of the industry: ASPN underperforms 97.59% of its industry peers.
- ASPN has a worse Return On Equity (-99.85%) than 89.16% of its industry peers.
- ASPN has a Return On Invested Capital of 2.43%. This is in the lower half of the industry: ASPN underperforms 62.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROIC | 2.43% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Operating Margin of ASPN (3.27%) is worse than 65.06% of its industry peers.
- With a decent Gross Margin value of 32.89%, ASPN is doing good in the industry, outperforming 65.06% of the companies in the same industry.
- ASPN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASPN is destroying value.
- The number of shares outstanding for ASPN has been increased compared to 1 year ago.
- ASPN has more shares outstanding than it did 5 years ago.
- ASPN has a worse debt/assets ratio than last year.
2.2 Solvency
- ASPN has an Altman-Z score of -0.51. This is a bad value and indicates that ASPN is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -0.51, ASPN is not doing good in the industry: 86.75% of the companies in the same industry are doing better.
- ASPN has a debt to FCF ratio of 46.99. This is a negative value and a sign of low solvency as ASPN would need 46.99 years to pay back of all of its debts.
- ASPN's Debt to FCF ratio of 46.99 is in line compared to the rest of the industry. ASPN outperforms 44.58% of its industry peers.
- ASPN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
- ASPN has a Debt to Equity ratio of 0.31. This is in the better half of the industry: ASPN outperforms 74.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Altman-Z | -0.51 |
ROIC/WACC0.2
WACC12.01%
2.3 Liquidity
- A Current Ratio of 3.94 indicates that ASPN has no problem at all paying its short term obligations.
- ASPN has a Current ratio of 3.94. This is amongst the best in the industry. ASPN outperforms 90.36% of its industry peers.
- ASPN has a Quick Ratio of 3.33. This indicates that ASPN is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.33, ASPN belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 |
3. Growth
3.1 Past
- The earnings per share for ASPN have decreased strongly by -129.73% in the last year.
- Looking at the last year, ASPN shows a very negative growth in Revenue. The Revenue has decreased by -14.74% in the last year.
- ASPN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.56% yearly.
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
3.2 Future
- The Earnings Per Share is expected to grow by 41.38% on average over the next years. This is a very strong growth
- Based on estimates for the next years, ASPN will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y-906.98%
EPS Next 2Y-65.78%
EPS Next 3Y-34.49%
EPS Next 5Y41.38%
Revenue Next Year-39.03%
Revenue Next 2Y-27.18%
Revenue Next 3Y-9.28%
Revenue Next 5Y4.06%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ASPN. In the last year negative earnings were reported.
- Also next year ASPN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 78.31% of the companies in the same industry are more expensive than ASPN, based on the Enterprise Value to EBITDA ratio.
- ASPN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 111.12 | ||
| EV/EBITDA | 8.09 |
4.3 Compensation for Growth
- A cheap valuation may be justified as ASPN's earnings are expected to decrease with -34.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.78%
EPS Next 3Y-34.49%
5. Dividend
5.1 Amount
- No dividends for ASPN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.61
-0.01 (-0.28%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners72.96%
Inst Owner Change-5.73%
Ins Owners1.11%
Ins Owner Change-0.13%
Market Cap298.37M
Revenue(TTM)352.85M
Net Income(TTM)-305.28M
Analysts76.92
Price Target6.63 (83.66%)
Short Float %10.98%
Short Ratio4.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-101.12%
Min EPS beat(2)-176.85%
Max EPS beat(2)-25.4%
EPS beat(4)2
Avg EPS beat(4)-32.06%
Min EPS beat(4)-176.85%
Max EPS beat(4)57.28%
EPS beat(8)6
Avg EPS beat(8)89.76%
EPS beat(12)10
Avg EPS beat(12)72.04%
EPS beat(16)10
Avg EPS beat(16)45.6%
Revenue beat(2)1
Avg Revenue beat(2)2.56%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)5.47%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-6.73%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)5.37%
Revenue beat(12)7
Avg Revenue beat(12)4.61%
Revenue beat(16)9
Avg Revenue beat(16)3.03%
PT rev (1m)0%
PT rev (3m)-32.17%
EPS NQ rev (1m)-3.26%
EPS NQ rev (3m)-80.74%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)-8.12%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)-22.1%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-9.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.85 | ||
| P/FCF | 111.12 | ||
| P/OCF | 5.69 | ||
| P/B | 0.98 | ||
| P/tB | 0.98 | ||
| EV/EBITDA | 8.09 |
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)0.03
FCFY0.9%
OCF(TTM)0.63
OCFY17.57%
SpS4.27
BVpS3.7
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROCE | 2.74% | ||
| ROIC | 2.43% | ||
| ROICexc | 3.79% | ||
| ROICexgc | 3.79% | ||
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% | ||
| FCFM | 0.76% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
F-Score4
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Debt/EBITDA | 2.77 | ||
| Cap/Depr | 221.9% | ||
| Cap/Sales | 14.1% | ||
| Interest Coverage | 0.81 | ||
| Cash Conversion | 154.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 | ||
| Altman-Z | -0.51 |
F-Score4
WACC12.01%
ROIC/WACC0.2
Cap/Depr(3y)1152.87%
Cap/Depr(5y)727.63%
Cap/Sales(3y)63.74%
Cap/Sales(5y)41.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
EPS Next Y-906.98%
EPS Next 2Y-65.78%
EPS Next 3Y-34.49%
EPS Next 5Y41.38%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
Revenue Next Year-39.03%
Revenue Next 2Y-27.18%
Revenue Next 3Y-9.28%
Revenue Next 5Y4.06%
EBIT growth 1Y-73.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-77.87%
EBIT Next 3Y9.21%
EBIT Next 5Y25.05%
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.02%
OCF growth 3YN/A
OCF growth 5YN/A
ASPEN AEROGELS INC / ASPN FAQ
Can you provide the ChartMill fundamental rating for ASPEN AEROGELS INC?
ChartMill assigns a fundamental rating of 3 / 10 to ASPN.
Can you provide the valuation status for ASPEN AEROGELS INC?
ChartMill assigns a valuation rating of 1 / 10 to ASPEN AEROGELS INC (ASPN). This can be considered as Overvalued.
How profitable is ASPEN AEROGELS INC (ASPN) stock?
ASPEN AEROGELS INC (ASPN) has a profitability rating of 1 / 10.
How financially healthy is ASPEN AEROGELS INC?
The financial health rating of ASPEN AEROGELS INC (ASPN) is 5 / 10.
What is the expected EPS growth for ASPEN AEROGELS INC (ASPN) stock?
The Earnings per Share (EPS) of ASPEN AEROGELS INC (ASPN) is expected to decline by -906.98% in the next year.